Please assess the completion status of the following clinical trial:

Trial Title: Study of Daclizumab in Patients With Chronic, Persistent Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* History of asthma for 6 or more months~* History of chronic persistent asthma requiring daily high dose inhaled corticosteroid for 3 or more months prior to enrollment~Exclusion Criteria:~* Patients with 10 or more pack years of smoking history or smoking within 12 months of study enrollment~* No significant disease other than asthma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).